Subject
Organic Chemistry,General Medicine,Biochemistry,Analytical Chemistry
Reference35 articles.
1. U.S. Food and Drug Administration, FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan), , (Accessed July 2023).
2. EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity. Some valsartan medicines being recalled across the EU, , (Accessed July 2023).
3. Current status and prospects of development of analytical methods for determining nitrosamine and N-nitroso impurities in pharmaceuticals;Wichitnithad;Talanta,2023
4. Nitrosamine contamination in pharmaceuticals: threat, impact, and control;Tuesuwan;J. Pharm. Sci.,2021
5. Simultaneous detection of nitrosamines and other sartan-related impurities in active pharmaceutical ingredients by supercritical fluid chromatography;Schmidtsdorff;J. Pharm. Biomed. Anal.,2019
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献